Research on murine models of cardiomyopathy has revealed that CB1-pathways promote a hypertrophic response from cardiomyocytes, whereas the stimulation of CB2 receptors is associated with the protection against cardiac hypertrophy. Here, CNR1 is linked to cardiomyopathy.